1. Bekesi, J.G., Holland, J.F., Cuttner, J., et al.: Chemoimmunotherapy in acute myelocytic leukemia. Proc. Am. Assoc. Cancer Res.18, 198 (1977)
2. Crowther, D., Powles, R.L., Bateman, C.J.T., et al.: Management of adult acute myelogenous leukaemia. Br. Med. J.1, 131?137 (1973)
3. Cuttner, J., Glidewell, O., Holland, J.F., Bekesi, J.G.: Chemoimmunotherapy of acute myelocytic leukemia with MER. In: Immunotherapy of Cancer: Present Status of Trials in Man. Terry, W.D., Windhorst, D. (eds.), pp. 405?412. New York: Raven 1978
4. Gale, D.G., McLennan, I.C.M.: Cytotoxic antibody in acute myeloblastic leukaemia during immunotherapy: lack of tumour specificity. Br. J. Cancer35, 280?287 (1977)
5. Galton, D.A.G., Kay, H.E.M., Reizenstein, P., Penchansky, M., Vogler, W.R., Whittaker, J.A.: Infection and second-remission rates in patients having immunotherapy for acute myeloid leukaemia. LancetII, 973 (1977)